Caprico Biotechnologies Competitors and Similar CompaniesClear all

Caprico Biotechnologies's competitors and similar companies include Bristol Myers Squibb, Biosonda, Novartis and Pfizer.
Caprico Biotechnologies
Caprico Biotechnologies
Caprico Biotechnologies (CBI) is a biotech company focused on developing and commercializing antibody reagents for flow cytometry applications.
Bristol Myers Squibb
Bristol Myers Squibb
Bristol-Myers Squibb (BMS) is a company engaged in the discovery, development, licensing, manufacturing, marketing, and distribution of biopharmaceutical products.
Biosonda
Biosonda
Biosonda is a biotechnology company that specializes in the research, development, production, and commercialization of hemocyanins.
Novartis
Novartis
Novartis is a company that researches, develops, manufactures, and markets healthcare products.
Pfizer
Pfizer
Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.
Founding Date
Founding Date
2013
Founding Date
1887
Founding Date
1992
Founding Date
1996
Founding Date
1849
Type
Type
Private
Type
Public
Type
Private
Type
Public
Type
Public
Tags
Locations
Locations
Norcross, US HQ
Locations
Princeton, US HQ
Mulgrave, AU
Pinewood, AU
Wien, AT
Braine L'alleud, BE
Bruxelles, BE
São Paulo, BR
see more
Locations
Miami, US HQ
Ñuñoa, CL
Locations
Basel, CH HQ
Tirana, AL
Buenos Aires, AR
Macquarie Park, AU
Kundl, AT
Unterlangkampfen, AT
Wien, AT
see more
Locations
New York, US HQ
Buenos Aires, AR
Villa Adelina, AR
Footscray, AU
Mulgrave, AU
Sydney, AU
Wien, AT
see more
Employees
Employees
17
Employees
34,100
Employees
N/A
Employees
75,883
Employees
81,0008% decrease
Valuation ($)
Valuation ($)
N/A
Valuation ($)
97.8 b
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
163.9 b

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$48.2b (FY, 2025)
Revenue (est.)
N/A
Revenue (est.)
$56.7b (FY, 2025)
Revenue (est.)
$62.6b (FY, 2025)
Cost of goods
Cost of goods
N/A
Cost of goods
$13.9b (FY, 2025)
Cost of goods
N/A
Cost of goods
$8.4b (FY, 2025)
Cost of goods
$16.1b (FY, 2025)
Gross profit
Gross profit
N/A
Gross profit
$34.3b (FY, 2025)
Gross profit
N/A
Gross profit
$49.8b (FY, 2025)
Gross profit
$46.5b (FY, 2025)
Net income
Net income
N/A
Net income
$7.1b (FY, 2025)
Net income
N/A
Net income
$14b (FY, 2025)
Net income
$7.8b (FY, 2025)

Operating

Phase III Trials Products
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
44 (FY, 2022)
Phase III Trials Products
32 (FY, 2024)
Phase III Trials Products (Oncology)
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
7 (FY, 2021)
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
27 (FY, 2021)
Phase III Trials Products (Oncology)
N/A
Registration Phase Products
Registration Phase Products
N/A
Registration Phase Products
N/A
Registration Phase Products
N/A
Registration Phase Products
8 (FY, 2022)
Registration Phase Products
5 (FY, 2024)

Funding

Total funding raised
Total funding raised
N/A
Total funding raised
$ 15.5m
Total funding raised
N/A
Total funding raised
$ 6.5m
Total funding raised
N/A
For sources of this data, please see the company profile

View Company Profiles

Bristol Myers Squibb
HQ
Princeton, US
Employees
34,100

Bristol-Myers Squibb (BMS) is a company engaged in the discovery, development, licensing, manufacturing, marketing, and distribution of biopharmaceutical products.

View company
Biosonda
HQ
Miami, US

Biosonda is a biotechnology company that specializes in the research, development, production, and commercialization of hemocyanins.

View company
Novartis
HQ
Basel, CH
Employees
75,883

Novartis is a company that researches, develops, manufactures, and markets healthcare products.

View company
Pfizer
HQ
New York, US
Employees
81,000↓ 8% decrease

Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.

View company